Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cresco Labs (6CQ) Stock Price & Analysis

6CQ Stock Chart & Stats

€0.49-€0.04(-7.40%)
At close: 5:30 PM GMT+1
EUR 0.55EUR 0.6EUR 0.65EUR 0.717 Jul31 Jul18 Aug31 Aug22 Sep1 Oct13 Oct
Day’s Range
EUR 0.49 - EUR 0.52
52-Week Range
EUR 0.49 - EUR 1.90
Previous Close
EUR 0.53
Volume
91
Average Volume (3M)
404
Market Cap
EUR 233.29M
Enterprise Value
EUR 1.17B
Total Cash (Recent Filing)
EUR 32.87M
Total Debt (Recent Filing)
EUR 592.02M
Price to Earnings (P/E)
―
Beta
1.63
Next Earnings
Nov 06, 2026 (Est.)
EPS Estimate
-0.01
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Operating Improvement

Positive EBIT and EBITDA, alongside a roughly 48% gross margin, show that the core cultivation, manufacturing, and sales platform can generate operating earnings. This provides a base for improving profitability if cost discipline and product mix hold.

Positive Operating Cash Flow

Positive TTM operating cash flow indicates the business is converting operating activity into cash, an important foundation for funding operations. Although conversion is not yet sufficient for full self-funding, cash generation supports greater financial resilience.

Integrated Multi-Channel Model

Operating across cultivation, manufacturing, wholesale, and owned retail gives Cresco multiple routes to reach regulated-market customers. This integrated model can support brand control, product diversification, and channel flexibility as state markets develop.

Bears Say

Persistent Net Losses

The company remains materially unprofitable despite operating improvement, with a roughly -16% net margin and negative returns on equity. Continued bottom-line losses can restrict reinvestment, weaken shareholder returns, and delay internally funded growth.

Elevated Leverage

Debt-to-equity of about 1.65 and declining equity reduce balance-sheet flexibility relative to the company’s current earnings power. Elevated leverage can constrain capital allocation, increase financial pressure, and make sustained investment harder during weaker periods.

Choppy Revenue Trend

Revenue has not followed a consistent upward path, with declines through 2023–2025 followed by a sharp TTM rebound. This uneven pattern makes demand and growth durability less certain and complicates planning for consistent earnings expansion.

Cresco Labs News

6CQ FAQ

What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was €0.49 and its highest was €1.90 in the past 12 months.
What is Cresco Labs’s market cap?
Cresco Labs’s market cap is €233.29M.
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s next earnings report is estimated for Nov 06, 2026 (not yet confirmed), which is in 5 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Aug 06, 2026. The company reported €0.036 earnings per share for the quarter, beating the consensus estimate of -€0.014 by €0.05.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -0.01.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 355,588,680 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of €0.036 in its last earnings report, beating expectations of -€0.014. Following the earnings report the stock price went down -0.513%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in DE:6CQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology